FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Abbott-Solvay deal no earth-shaker

Tools

Forbes' Matthew Herper says Abbott Laboratories' (ABT) purchase of Solvay Pharmaceuticals isn't going to change the company in a big way, but the price was right. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Solvay   Pharma deals   Abbott Laboratories